nach oben

Journal of Interventional Cardiac Electrophysiology

Erschienen in:

10.11.2018

Cardiac effects of CPAP treatment in patients with obstructive sleep apnea and atrial fibrillation

verfasst von: Asmaa M. Abumuamar, David Newman, Paul Dorian, Colin M. Shapiro

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Obstructive sleep apnea (OSA) has been recognized as an independent risk factor for the development and progression of atrial fibrillation (AF). We aimed to investigate the changes in heart rate and atrial and ventricular ectopy after continuous positive airway pressure (CPAP) treatment in patients with OSA and AF.

Methods

Consecutive patients with AF underwent ambulatory sleep monitoring, and OSA was defined as an Apnea-Hypopnea-Index (AHI) ≥ 5/h. Treated patients completed in-laboratory CPAP titration study. A 24-h ECG Holter was performed at baseline and at 3 and 6 months after CPAP treatment.

Results

One hundred patients (70% males) with AF were included in the final analysis. OSA was diagnosed in 85% of patients. There were no significant changes in mean 24-h heart rate in patients with paroxysmal or permanent AF at 3 and 6 months of treatment compared to baseline. In patients with paroxysmal AF (n = 29), atrial and ventricular ectopy counts/24 h significantly decreased at 3 months compared to baseline (median (IQR) 351 (2049) to 57 (182), P = 0.002; 68 (105) to 16 (133), P = 0.01 respectively). At 6 months follow-up, the atrial ectopy count/24 h significantly decreased in patients with paroxysmal AF compared to baseline (median (IQR) 351 (2049) to 31 (113), P = 0.016, n = 14). In patients with permanent AF (n = 15), there was a significant reduction in ventricular ectopy count/24 h at 3 months compared to baseline (median (IQR) 100 (1116) to 33 (418), P = 0.02).

Conclusions

There is a significant decrease in atrial and ventricular ectopy count/24 h in patients with AF and OSA at 3 and 6 months of CPAP treatment compared to baseline.

Voight J, Akkaya M, Somasundaram P, Karim R, Valliani S, Kwon Y, et al. Risk of new-onset atrial fibrillation and stroke after radiofrequency ablation of isolated, typical atrial flutter. Heart Rhythm. 2014;11(11):1884–9. https://doi.org/10.1016/j.hrthm.2014.06.038.CrossRefPubMed

Mooe T, Gullsby S, Rabben T, Eriksson P. Sleep-disordered breathing: a novel predictor of atrial fibrillation after coronary artery bypass surgery. Coron Artery Dis. 1996;7(6):475–8.CrossRefPubMed

Abumuamar AM, Mollayeva T, Sandor P, Newman D, Nanthakumar K, Shapiro CM. Efficacy of continuous positive airway pressure treatment in patients with cardiac arrhythmia and obstructive sleep apnea: what is the evidence? Clinical Medicine Insights: Therapeutics. 2017;9(Supplementary Material_734227):1179559X17734227. https://doi.org/10.1177/1179559X17734227.CrossRef

Dimitri H, Ng M, Brooks AG, Kuklik P, Stiles MK, Lau DH, et al. Atrial remodeling in obstructive sleep apnea: implications for atrial fibrillation. Heart Rhythm. 2012;9(3):321–7. https://doi.org/10.1016/j.hrthm.2011.10.017.CrossRefPubMed

Chen C-Y, Ho C-H, Chen C-L, Yu C-C. Nocturnal desaturation is associated with atrial fibrillation in patients with ischemic stroke and obstructive sleep apnea. JCSM. 2017;13(5):729–35. https://doi.org/10.5664/jcsm.6594.CrossRefPubMed

Jeong E-M, Liu M, Sturdy M, Gao G, Varghese ST, Sovari AA, et al. Metabolic stress, reactive oxygen species, and arrhythmia. J Mol Cell Cardiol. 2012;52(2):454–63. https://doi.org/10.1016/j.yjmcc.2011.09.018.CrossRefPubMed

Chan KH, Wilcox I. Obstructive sleep apnea: novel trigger and potential therapeutic target for cardiac arrhythmias. Expert Rev Cardiovasc Ther. 2010;8(7):981–94. https://doi.org/10.1586/erc.10.80.CrossRefPubMed

Camen G, Clarenbach CF, Stöwhas A-C, Rossi VA, Sievi NA, Stradling JR, et al. The effects of simulated obstructive apnea and hypopnea on arrhythmic potential in healthy subjects. Eur J Appl Physiol. 2013;113(2):489–96. https://doi.org/10.1007/s00421-012-2457-y.CrossRefPubMed

Clarenbach CF, Camen G, Sievi NA, Wyss C, Stradling JR, Kohler M. Effect of simulated obstructive hypopnea and apnea on thoracic aortic wall transmural pressures. J Appl Physiol. 2013;115(5):613–7. https://doi.org/10.1152/japplphysiol.00439.2013.CrossRefPubMedPubMedCentral

10.

Orban M, Bruce CJ, Pressman GS, Leinveber P, Romero-Corral A, Korinek J, et al. Dynamic changes of left ventricular performance and left atrial volume induced by the mueller maneuver in healthy young adults and implications for obstructive sleep apnea, atrial fibrillation, and heart failure. Am J Cardiol. 2008;102(11):1557–61. https://doi.org/10.1016/j.amjcard.2008.07.050.CrossRefPubMedPubMedCentral

11.

Mazza A, Bendini MG, Cristofori M, Nardi S, Leggio M, De Cristofaro R, et al. Baseline apnoea/hypopnoea index and high-sensitivity C-reactive protein for the risk of recurrence of atrial fibrillation after successful electrical cardioversion: a predictive model based upon the multiple effects of significant variables. Europace. 2009;11(7):902–9. https://doi.org/10.1093/europace/eup107.CrossRefPubMed

12.

Narkiewicz K, Kato M, Phillips BG, Pesek CA, Davison DE, Somers VK. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation. 1999;100(23):2332–5.CrossRefPubMed

13.

Mills PJ, Kennedy BP, Loredo JS, Dimsdale JE, Ziegler MG. Effects of nasal continuous positive airway pressure and oxygen supplementation on norepinephrine kinetics and cardiovascular responses in obstructive sleep apnea. Europace. 2006;100(1):343–8. https://doi.org/10.1152/japplphysiol.00494.2005.CrossRef

14.

Karamanlı H, Özol D, Ugur KS, Yıldırım Z, Armutçu F, Bozkurt B, et al. Influence of CPAP treatment on airway and systemic inflammation in OSAS patients. Sleep & Breathing. 2014;18(2):251–6. https://doi.org/10.1007/s11325-012-0761-8.CrossRef

15.

Bayir PT, Demirkan B, Bayir O, Duyuler S, Firat H, Güray U, et al. Impact of continuous positive airway pressure therapy on atrial electromechanical delay and P-wave dispersion in patients with obstructive sleep apnea. Ann Noninvasive Electrocardiol. 2014;19(3):226–33. https://doi.org/10.1111/anec.12106.CrossRefPubMed

16.

Linz D, McEvoy RD, Cowie MR, Somers VK, Nattel S, Lévy P, et al. Associations of obstructive sleep apnea with atrial fibrillation and continuous positive airway pressure treatment: a review. JAMA Cardiol. 2018;3(6):532–40. https://doi.org/10.1001/jamacardio.2018.0095.CrossRefPubMed

17.

A comparison of two nights of ambulatory sleep testing in arrhythmia patients. - PubMed - NCBI. (n.d.). Retrieved August 1, 2018, from https://www.ncbi.nlm.nih.gov/pubmed/29973998

18.

Abumuamar AM, Dorian P, Newman D, Shapiro CM. The STOP-BANG questionnaire shows an insufficient specificity for detecting obstructive sleep apnea in patients with atrial fibrillation. J Sleep Res. 2018;0(0):e12702. https://doi.org/10.1111/jsr.12702.CrossRef

19.

Holmqvist F, Guan N, Zhu Z, Kowey PR, Allen LA, Fonarow GC, et al. Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation—results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am Heart J. 2015;169(5):647–654.e2. https://doi.org/10.1016/j.ahj.2014.12.024.CrossRefPubMed

20.

Kanagala R, Murali NS, Friedman PA, Ammash NM, Gersh BJ, Ballman KV, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation. 2003;107(20):2589–94. https://doi.org/10.1161/01.CIR.0000068337.25994.21.CrossRefPubMed

21.

Dediu GN, Dumitrache-Rujinski S, Lungu R, Frunză S, Diaconu C, Bartoş D, et al. Positive pressure therapy in patients with cardiac arrhythmias and obstructive sleep apnea. Pneumologia. 2015;64(1):18–22.PubMed

22.

Harbison J, O’Reilly P, McNicholas WT. Cardiac rhythm disturbances in the obstructive sleep apnea syndrome: effects of nasal continuous positive airway pressure therapy. Chest. 2000;118(3):591–5.CrossRefPubMed

23.

Ryan CM, Usui K, Floras JS, Bradley TD. Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea. Thorax. 2005;60(9):781–5. https://doi.org/10.1136/thx.2005.040972.CrossRefPubMedPubMedCentral

24.

Acharya T, Tringali S, Bhullar M, Nalbandyan M, Ilineni VK, Carbajal E, et al. Frequent atrial premature complexes and their association with risk of atrial fibrillation. Am J Cardiol. 2015;116(12):1852–7. https://doi.org/10.1016/j.amjcard.2015.09.025.CrossRefPubMed

25.

Linz D, Hohl M, Ukena C, Mahfoud F, Wirth K, Neuberger H-R, et al. Obstructive respiratory events and premature atrial contractions after cardioversion. Eur Respir J. 2015;45(5):1332–40. https://doi.org/10.1183/09031936.00175714.CrossRefPubMed

26.

Schlatzer C, Schwarz EI, Sievi NA, Clarenbach CF, Gaisl T, Haegeli LM, et al. Intrathoracic pressure swings induced by simulated obstructive sleep apnoea promote arrhythmias in paroxysmal atrial fibrillation. Europace. 2016;18(1):64–70. https://doi.org/10.1093/europace/euv122.CrossRefPubMed

27.

Namtvedt SK, Randby A, Einvik G, Hrubos-Strøm H, Somers VK, Røsjø H, et al. Cardiac arrhythmias in obstructive sleep apnea (from the Akershus Sleep Apnea Project). Am J Cardiol. 2011;108(8):1141–6. https://doi.org/10.1016/j.amjcard.2011.06.016.CrossRefPubMed

28.

Serizawa N, Yumino D, Kajimoto K, Tagawa Y, Takagi A, Shoda M, et al. Impact of sleep-disordered breathing on life-threatening ventricular arrhythmia in heart failure patients with implantable cardioverter-defibrillator. Am J Cardiol. 2008;102(8):1064–8. https://doi.org/10.1016/j.amjcard.2008.05.057.CrossRefPubMed

29.

Kwon Y, Koene RJ, Kwon O, Kealhofer JV, Adabag S, Duval S. Effect of sleep-disordered breathing on appropriate implantable cardioverter-defibrillator therapy in patients with heart failure: a systematic review and meta-analysis. Circ Arrhythm Electrophysiol. 2017;10(2):–e004609. https://doi.org/10.1161/CIRCEP.116.004609.

30.

Weaver TE, Grunstein RR. Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Proc Am Thorac Soc. 2008;5(2):173–8. https://doi.org/10.1513/pats.200708-119MG.CrossRefPubMedPubMedCentral

31.

Abumuamar AM, Dorian P, Newman D, Shapiro CM. The prevalence of obstructive sleep apnea in patients with atrial fibrillation. Clin Cardiol. 2018;41(5):601–7. https://doi.org/10.1002/clc.22933.CrossRefPubMedPubMedCentral

Titel: Cardiac effects of CPAP treatment in patients with obstructive sleep apnea and atrial fibrillation
verfasst von: Asmaa M. Abumuamar
David Newman
Paul Dorian
Colin M. Shapiro
Publikationsdatum: 10.11.2018
Verlag: Springer US
Erschienen in: Journal of Interventional Cardiac Electrophysiology / Ausgabe 3/2019
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI: https://doi.org/10.1007/s10840-018-0482-4

Neu im Fachgebiet Kardiologie

23.04.2024 | Ablationstherapie | Nachrichten

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Cardiac effects of CPAP treatment in patients with obstructive sleep apnea and atrial fibrillation

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet Kardiologie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Kardiologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2019

Ortner’s syndrome after cryoballoon ablation

Single-brand dual-chamber discriminators to prevent inappropriate shocks in patients implanted with prophylactic implantable cardioverter defibrillators: a propensity-weighted comparison of single- and dual-chamber devices

Comparison of efficacy and safety of laser balloon and cryoballoon ablation for atrial fibrillation—a meta-analysis

Clinical evidence of autonomic dysfunction due to atrial fibrillation: implications for rhythm control strategy

The relationship between obstructive sleep apnea and recurrence of atrial fibrillation after pulmonary vein isolation using a contact force–sensing catheter

Hemoptysis as a side effect of cryoballoon pulmonary vein isolation in atrial fibrillation: a retrospective case-control study

Neu im Fachgebiet Kardiologie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Kardiologie